ConductScience.org, home

Paper37323948

Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.

Zhu H and 8 others. Int J Nanomedicine, 2023. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis. Papers, record 37323948. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37323948

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
PubMed
Journal
Int J Nanomedicine
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2023-06-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhu HHuihttps://orcid.org/0000-0002-6968-6499
2Yang KKe
3Yao HHuan
4Chen XXueying
5Yan SShujinhttps://orcid.org/0009-0003-2753-1370
6He YYiman
7Cao YYang
8Luo JJie
9Wang DDong

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Triple Negative Breast NeoplasmsMajor topic
Hyperthermia, InducedMajor topic
Female
Humans
Photothermal Therapy
Phototherapy
Tissue Distribution
Immunogenic Cell Death
Doxorubicin

Source PubMed

Download CSV of topics

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135787915Recent advances in nanoparticle-based photothermal therapy for breast cancer.J Control Release2022https://conductscience.org/library/papers/35787915PubMed
232382473Emerging Technologies for Real-Time Intraoperative Margin Assessment in Future Breast-Conserving Surgery.Adv Sci (Weinh)2020https://conductscience.org/library/papers/32382473PubMed
324148240Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent.Biomaterials2014https://conductscience.org/library/papers/24148240PubMed
433421711Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.Biomaterials2021https://conductscience.org/library/papers/33421711PubMed
532898630Induction of immunogenic cell death of cancer cells through nanoparticle-mediated dual chemotherapy and photothermal therapy.Int J Pharm2020https://conductscience.org/library/papers/32898630PubMed
636538368Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.ACS Appl Mater Interfaces2023https://conductscience.org/library/papers/36538368PubMed
736525971IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.Cancer Cell2023https://conductscience.org/library/papers/36525971PubMed
831350406Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death.Nat Commun2019https://conductscience.org/library/papers/31350406PubMed
935995278Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation.Pharmacol Ther2022https://conductscience.org/library/papers/35995278PubMed
1030346728Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.Acc Chem Res2018https://conductscience.org/library/papers/30346728PubMed
1134280474Progress and challenges of immunotherapy in triple-negative breast cancer.Biochim Biophys Acta Rev Cancer2021https://conductscience.org/library/papers/34280474PubMed
1232209603Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.J Immunother Cancer2020https://conductscience.org/library/papers/32209603PubMed
1335339668Recent advances of nanodrug delivery system in the treatment of hematologic malignancies.Semin Cancer Biol2022https://conductscience.org/library/papers/35339668PubMed
1429178534Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies?Angew Chem Int Ed Engl2018https://conductscience.org/library/papers/29178534PubMed
1536385713Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial.J Pineal Res2023https://conductscience.org/library/papers/36385713PubMed
1635447074Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche.Cell2022https://conductscience.org/library/papers/35447074PubMed
1736427657NIR-triggered ligand-presenting nanocarriers for enhancing synergistic photothermal-chemotherapy.J Control Release2023https://conductscience.org/library/papers/36427657PubMed
1826348965Principles of nanoparticle design for overcoming biological barriers to drug delivery.Nat Biotechnol2015https://conductscience.org/library/papers/26348965PubMed
1936203955An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer.Bioact Mater2023https://conductscience.org/library/papers/36203955PubMed
2034754128Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.Nat Rev Clin Oncol2022https://conductscience.org/library/papers/34754128PubMed

See all 52 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42539503Latest advances in nanodrug delivery systems for modulating the immune microenvironment in triple-negative breast cancer.Front Immunol2026https://conductscience.org/library/papers/42539503PubMed
42370175Multimodal imaging-guided NIR-II photo-gas nanoplatform amplifies PD-1 blockade for synergistic TNBC therapy.Theranostics2026https://conductscience.org/library/papers/42370175PubMed
42369649Carbon-based nanomaterials in biomedicine and technology.Front Chem2026https://conductscience.org/library/papers/42369649PubMed
42149294Overcoming barriers: mechanisms and strategies of nanoparticles in overcoming the blood-brain barrier and drug resistance in glioblastomas.J Egypt Natl Canc Inst2026https://conductscience.org/library/papers/42149294PubMed
40766970Reprogramming the tumor-immune landscape via nanomaterial-induced immunogenic cell death: a mini review.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/40766970PubMed
40599401Advancements in Nano-Delivery Systems for Photodynamic and Photothermal Therapy to Induce Immunogenic Cell Death in Tumor Immunotherapy.Int J Nanomedicine2025https://conductscience.org/library/papers/40599401PubMed
39725974Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer.J Nanobiotechnology2024https://conductscience.org/library/papers/39725974PubMed
39325106Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects.Clin Exp Med2024https://conductscience.org/library/papers/39325106PubMed
38815129Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer.ACS Biomater Sci Eng2024https://conductscience.org/library/papers/38815129PubMed
38774648Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot.Front Cell Dev Biol2024https://conductscience.org/library/papers/38774648PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37323948

GET https://conductscience.org/api/papers/v1/37323948/references?page=2